In the latest session, RXO Inc (NYSE: RXO) closed at $21.82 up 2.06% from its previous closing price of $21.38. In other words, the price has increased by $+0.44 from its previous closing price. On the day, 704577 shares were traded.
Ratios:
For a deeper understanding of RXO Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 510.98 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 102.20. For the most recent quarter (mrq), Quick Ratio is recorded 1.17 and its Current Ratio is at 1.17. In the meantime, Its Debt-to-Equity ratio is 0.94 whereas as Long-Term Debt/Eq ratio is at 0.85.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, TD Cowen on February 09, 2024, Reiterated its Market Perform rating but revised its target price to $19.50 from $16.50 previously.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Feb 09 ’24 when MFN Partners, LP bought 913,186 shares for $20.29 per share. The transaction valued at 18,528,544 led to the insider holds 15,588,555 shares of the business.
MFN Partners, LP bought 919,720 shares of RXO for $19,350,909 on Feb 08 ’24. The 10% Owner now owns 14,675,369 shares after completing the transaction at $21.04 per share. On Feb 02 ’24, another insider, MFN Partners, LP, who serves as the 10% Owner of the company, bought 747,424 shares for $20.25 each. As a result, the insider paid 15,135,336 and bolstered with 13,755,649 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXO now has a Market Capitalization of 2.56B and an Enterprise Value of 3.12B. As of this moment, RXO’s Price-to-Earnings (P/E) ratio for their current fiscal year is 655.26, and their Forward P/E ratio for the next fiscal year is 32.56. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.65 while its Price-to-Book (P/B) ratio in mrq is 4.30. Its current Enterprise Value per Revenue stands at 0.79 whereas that against EBITDA is 30.27.
Stock Price History:
Over the past 52 weeks, RXO has reached a high of $24.33, while it has fallen to a 52-week low of $16.94. The 50-Day Moving Average of the stock is 21.08, while the 200-Day Moving Average is calculated to be 20.50.
Shares Statistics:
For the past three months, RXO has traded an average of 644.32K shares per day and 723.25k over the past ten days. A total of 117.03M shares are outstanding, with a floating share count of 114.75M. Insiders hold about 2.00% of the company’s shares, while institutions hold 98.92% stake in the company. Shares short for RXO as of Mar 28, 2024 were 2.95M with a Short Ratio of 4.58, compared to 2.75M on Feb 29, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.52% and a Short% of Float of 4.99%.
Earnings Estimates
There are 16 different market analysts currently analyzing its stock. On average, analysts expect EPS of -$0.03 for the current quarter, with a high estimate of $0 and a low estimate of -$0.06, while EPS last year was $0.11. The consensus estimate for the next quarter is $0.03, with high estimates of $0.07 and low estimates of -$0.01.
Analysts are recommending an EPS of between $0.41 and $0.1 for the fiscal current year, implying an average EPS of $0.24. EPS for the following year is $0.69, with 16 analysts recommending between $0.81 and $0.5.
Revenue Estimates
A total of 12 analysts believe the company’s revenue will be $930.48M this quarter.It ranges from a high estimate of $979.9M to a low estimate of $870.66M. As of the current estimate, RXO Inc’s year-ago sales were $1.01B, an estimated decrease of -7.90% from the year-ago figure. For the next quarter, 12 analysts are estimating revenue of $967.02M, an increase of 0.40% over than the figure of -$7.90% in the same quarter last year. There is a high estimate of $1.03B for the next quarter, whereas the lowest estimate is $915M.
A total of 14 analysts have provided revenue estimates for RXO’s current fiscal year. The highest revenue estimate was $4.26B, while the lowest revenue estimate was $3.84B, resulting in an average revenue estimate of $4.04B. In the same quarter a year ago, actual revenue was $3.93B, up 2.80% from the average estimate. Based on 14 analysts’ estimates, the company’s revenue will be $4.49B in the next fiscal year. The high estimate is $5.02B and the low estimate is $4.11B. The average revenue growth estimate for next year is up 11.20% from the average revenue estimate for this year.
